In diabetic cardiomyopathy, knocking down GnT-V reduces HG-induced cardiac hypertrophy by depending on an integrinβ1-ERK1/2 dependent manner, and alleviates myocardial fibrosis by inhibiting the TGF-β1/Smads signaling pathway. Here, TGFB1 is linked to cardiac hypertrophy.